Upgrade to SI Premium - Free Trial

Amgen (AMGN) & Allergan (AGN) Report U.S. FDA Submission of Biosimilar Biologics License Application For ABP 980

July 31, 2017 9:03 AM
Amgen (NASDAQ: AMGN) and Allergan plc. (NYSE: AGN) today announced the submission of a Biologics License Application (BLA) to ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News FDA Hot Corp. News Hot FDA News Management Comments

Next Articles